UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Biochemical pharmacology, ISSN 0006-2952, 11/2016, Volume 120, pp. 1 - 14
Nanoparticles | Vaccine | SAPN | Adjuvant | Rationally designed | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Recombinant Proteins - therapeutic use | Veterinary Drugs - adverse effects | History, 21st Century | Nanoparticles - chemistry | Humans | Vaccines, Synthetic - immunology | Antigens - therapeutic use | Vaccines - chemistry | Allergy and Immunology - history | Nanoparticles - therapeutic use | Vaccines, Subunit - adverse effects | Biopharmaceutics - history | Adjuvants, Immunologic - therapeutic use | Communicable Diseases - veterinary | Chemistry, Pharmaceutical - trends | Vaccines, Synthetic - chemistry | History, 20th Century | Recombinant Proteins - chemistry | Veterinary Drugs - immunology | Protein Engineering - trends | Antigens - chemistry | Communicable Disease Control - trends | Biopharmaceutics - methods | Drug Delivery Systems - trends | Protein Engineering - veterinary | Drug Delivery Systems - adverse effects | Veterinary Drugs - chemistry | Veterinary Drugs - therapeutic use | Drug Delivery Systems - veterinary | Nanoparticles - adverse effects | Recombinant Proteins - adverse effects | Vaccines - therapeutic use | Adjuvants, Immunologic - adverse effects | Antigens - adverse effects | Vaccines, Subunit - therapeutic use | Vaccines, Synthetic - adverse effects | Adjuvants, Immunologic - chemistry | Allergy and Immunology - trends | Drug Design | Chemistry, Pharmaceutical - history | Communicable Disease Control - history | Vaccines, Subunit - chemistry | Biopharmaceutics - trends | Vaccines - immunology | Vaccines, Synthetic - therapeutic use | Vaccines, Subunit - immunology | Protein Folding | Vaccines - adverse effects | Animals | Recombinant Proteins - immunology | Communicable Diseases - immunology | Antigens - immunology | History, 19th Century | Vaccines | Index Medicus | Rationally Designed
Journal Article
Vaccine, ISSN 0264-410X, 2015, Volume 34, Issue 3, pp. 313 - 319
Allergy and Immunology | Cytomegalovirus | Vaccine | CMV gB | Adolescent | Immunology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Cytomegalovirus Vaccines - adverse effects | Adjuvants, Immunologic - administration & dosage | Vaccines, Subunit - genetics | Humans | DNA, Viral - analysis | Cytomegalovirus Infections - immunology | Vaccines, Synthetic - immunology | Cytomegalovirus Vaccines - administration & dosage | Antibodies, Viral - blood | Drug-Related Side Effects and Adverse Reactions - pathology | Adjuvants, Immunologic - adverse effects | Cytomegalovirus Infections - prevention & control | Vaccines, Synthetic - adverse effects | Blood - virology | Polymerase Chain Reaction | Polysorbates - administration & dosage | Female | Immunization Schedule | Vaccines, Subunit - adverse effects | Child | Cytomegalovirus Vaccines - genetics | Placebos - administration & dosage | Antigens, Viral - analysis | Polysorbates - adverse effects | Viral Envelope Proteins - genetics | Double-Blind Method | Vaccines, Synthetic - genetics | Squalene - administration & dosage | Urine - virology | Vaccines, Subunit - immunology | Squalene - adverse effects | Drug-Related Side Effects and Adverse Reactions - epidemiology | Vaccines, Subunit - administration & dosage | Viral Envelope Proteins - immunology | Vaccines, Synthetic - administration & dosage | DNA, Viral - genetics | Cytomegalovirus Vaccines - immunology | Clinical trials | Medical colleges | Vaccines | Teenage girls | Antigens | Cytomegalovirus infections | Vaccination | Urine | Confidence intervals | Substance abuse treatment | Consent | Hispanic Americans | Population | Infections | Index Medicus | adolescent | vaccine | cytomegalovirus
Journal Article
Vaccine, ISSN 0264-410X, 2012, Volume 31, Issue 3, pp. 524 - 532
Allergy and Immunology | Respiratory syncytial virus (RSV) | Palivizumab | Fusion protein (F protein) | Competitive ELISA | SF9 insect cell | Microneutralization | Aluminum phosphate | Anti-F IgG | Nanoparticle vaccine | Immunology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Fundamental and applied biological sciences. Psychology | Biological and medical sciences | Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) | Microbiology | Applied microbiology | Recombinant Fusion Proteins - immunology | Single-Blind Method | Biotechnology | Respiratory Syncytial Virus Vaccines - immunology | Adjuvants, Immunologic - administration & dosage | Aluminum Compounds - adverse effects | Phosphates - administration & dosage | Recombinant Fusion Proteins - adverse effects | Humans | Middle Aged | Male | Nanoparticles - adverse effects | Vaccines, Synthetic - immunology | Antibodies, Viral - blood | Adjuvants, Immunologic - adverse effects | Young Adult | Respiratory Syncytial Virus Vaccines - adverse effects | Sf9 Cells | Technology, Pharmaceutical | Vaccines, Virosome - immunology | Vaccines, Synthetic - adverse effects | Placebos - adverse effects | Adult | Female | Placebos - administration & dosage | Recombinant Fusion Proteins - administration & dosage | Vaccines, Virosome - administration & dosage | Vaccines, Synthetic - genetics | Vaccines, Virosome - genetics | Animals | Aluminum Compounds - administration & dosage | Phosphates - adverse effects | Vaccines, Virosome - adverse effects | Respiratory Syncytial Virus Vaccines - administration & dosage | Adolescent | Recombinant Fusion Proteins - genetics | Nanoparticles - administration & dosage | Vaccines, Synthetic - administration & dosage | Respiratory Syncytial Virus Vaccines - genetics | Antibodies, Neutralizing - blood | Virus diseases | Phosphates | Vaccines | Immunoglobulin G | Enzyme-linked immunosorbent assay | Proteins | Nanoparticles | Infections | Index Medicus
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 2015, Volume 15, Issue 10, pp. 1156 - 1166
Infectious Disease | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Hemorrhagic Fever, Ebola - prevention & control | Vasculitis - epidemiology | Arthritis - epidemiology | Humans | Middle Aged | Vasculitis - pathology | Antigens, Viral - genetics | Male | Vaccination - adverse effects | Vaccines, Synthetic - immunology | Ebolavirus - genetics | Antibodies, Viral - blood | Dermatitis - epidemiology | Drug Carriers | Drug-Related Side Effects and Adverse Reactions - pathology | Young Adult | Arthritis - chemically induced | Vaccination - methods | Vaccines, Synthetic - adverse effects | Vesiculovirus - genetics | Adult | Ebola Vaccines - immunology | Female | Vasculitis - chemically induced | Placebos - administration & dosage | Double-Blind Method | Arthritis - pathology | Ebola Vaccines - administration & dosage | Ebola Vaccines - adverse effects | Switzerland | Drug-Related Side Effects and Adverse Reactions - epidemiology | Dermatitis - pathology | Adolescent | Aged | Vaccines, Synthetic - administration & dosage | Ebola virus | Hospitals | Clinical trials | Product development | Cross infection | Vaccines | Nosocomial infections | Health aspects | Epidemics | Disease | Arthritis | Dermatitis | Ankle | Wrist | Consortia | Pain | Adenoviruses | Fingers & toes | Skin | Public health | Index Medicus
Journal Article
Vaccine, ISSN 0264-410X, 2011, Volume 29, Issue 42, pp. 7229 - 7241
Allergy and Immunology | Human | Development | Vaccine | Safety | Immunogenicity | Dengue | Immunology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Immunization, Secondary - adverse effects | Humans | Vaccination - adverse effects | Vaccines, Synthetic - immunology | Dengue Vaccines - genetics | Clinical Trials, Phase III as Topic | Animal Experimentation | Vaccination - methods | Dengue Virus - immunology | Vaccines, Synthetic - adverse effects | France | Yellow Fever Vaccine - adverse effects | Yellow Fever Vaccine - immunology | Vaccines, Synthetic - genetics | Immunization, Secondary - methods | Drug Discovery | Dengue - prevention & control | Dengue Vaccines - immunology | Dengue Virus - genetics | Vaccines, Attenuated - immunology | Yellow Fever Vaccine - genetics | Animals | Dengue Vaccines - adverse effects | Vaccines, Attenuated - adverse effects | Vaccines, Attenuated - genetics | Medical research | Dendritic cells | Vaccination | Medicine, Experimental | Clinical trials | Vaccines | Studies | Industrial development | Cell culture | Dengue fever | Technological change | Viruses | RNA polymerase | Tropical diseases | Index Medicus
Journal Article
Vaccine, ISSN 0264-410X, 2012, Volume 30, Issue 52, pp. 7594 - 7600
Allergy and Immunology | Vaccine | Als3p | Phase 1 | Candida | First-in-human | Staphylococcus aureus | Immunology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Adjuvants, Immunologic - administration & dosage | Fungal Vaccines - adverse effects | Immunoglobulin G - blood | Humans | Fungal Vaccines - genetics | Fungal Vaccines - immunology | Vaccines, Synthetic - immunology | Adjuvants, Immunologic - adverse effects | Candida albicans - genetics | Fungal Vaccines - administration & dosage | Vaccines, Synthetic - adverse effects | Leukocytes, Mononuclear - immunology | Staphylococcal Vaccines - adverse effects | Adult | Staphylococcal Vaccines - immunology | Alum Compounds - adverse effects | Placebos - administration & dosage | Staphylococcus aureus - genetics | Interleukin-17 - secretion | Interferon-gamma - secretion | Vaccines, Synthetic - genetics | Antibodies, Fungal - blood | Staphylococcal Vaccines - administration & dosage | Candida albicans - immunology | B-Lymphocytes - immunology | Staphylococcal Vaccines - genetics | Immunoglobulin A - blood | Staphylococcus aureus - immunology | T-Lymphocytes - immunology | Vaccines, Synthetic - administration & dosage | Alum Compounds - administration & dosage | Adults | Immune response | Vaccines | T cells | Index Medicus | vaccine | phase 1 | first-in-human
Journal Article